WHERE DO WE STAND WITH PRIMARY TREATMENT OF BREAST CANCER

被引：0
|
作者：
SPRATT, JS
机构：
[1] CANC RES CTR,BUSINESS LOOP 70 & GARTH AVE,COLUMBIA,MO 65201
[2] ELLIS FISCHEL STATE CANC HOSP,COLUMBIA,MO 65201
来源：
MISSOURI MEDICINE | 1974年 / 71卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：676 / 678
页数：3
相关论文
共 50 条
  • [41] Magnesium treatment for asthma - Where do we stand?
    Noppen, M
    CHEST, 2002, 122 (02) : 396 - 398
  • [42] Lung cancer in Pakistan, where do we stand?
    Majeed, Farhan Ahmed
    Azeem, Abdul Rehman
    Farhan, Nabeela
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2019, 69 (03) : 405 - 408
  • [43] Marine Compounds and Cancer: Where Do We Stand?
    Dyshlovoy, Sergey A.
    Honecker, Friedemann
    MARINE DRUGS, 2015, 13 (09): : 5657 - 5665
  • [44] Heparins and cancer survival: where do we stand?
    Noble, Simon
    THROMBOSIS RESEARCH, 2014, 133 : S133 - S138
  • [45] Prevention and treatment of stroke: Where do we stand?
    Gibaldi, M
    JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (09): : 784 - 790
  • [46] Immunotherapy and immunoprevention of cancer: where do we stand?
    Cavallo, F
    Curcio, C
    Forni, G
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (05) : 717 - 726
  • [47] Where do we stand?
    Thompson, ID
    FORESTRY CHRONICLE, 2003, 79 (03): : 381 - 382
  • [48] Where do we stand?
    不详
    INTERNATIONAL JOURNAL OF PRODUCTIVITY AND PERFORMANCE MANAGEMENT, 2010, 59 (03) : 79 - 86
  • [49] Immunotherapy in Gastrointestinal Cancer: Where Do We Stand?
    Tannapfel, Andrea
    Reinacher-Schick, Anke
    VISCERAL MEDICINE, 2019, 35 (01) : 1 - 2
  • [50] Lung cancer screening: where do we stand?
    Hardavella, Georgia
    Frille, Armin
    Sreter, Katherina Bernadette
    Atrafi, Florence
    Yousaf-Khan, Uraujh
    Beyaz, Ferhat
    Kyriakou, Fotis
    Bellou, Elena
    Mullin, Monica L.
    Janes, Sam M.
    BREATHE, 2024, 20 (02)
12345